Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
Bayer, a leading healthcare product manufacturer, said today it will invest up to 100 million euros ($129.22 million) in the coming five years to establish a research and development (R&D) center in
The need for German pharmaceutical company Bayer to restructure is discussed almost daily in the press. In these reports, the name of one blockbuster always comes up: Xarelto. Its substance patent
Bayer AG, one of the top five hundred enterprises in the world, attaches great importance to its IPR development. In 2009, a small private enterprise in Henan province (China) tried to establish
Recently, Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc. filed a complaint in the Northern District of West Virginia against Mylan Pharmaceuticals Inc. and Mylan Inc. alleging patent
For years, Bayer has fought a fierce pan-European battle over its cancer drug Nexavar. The dispute concerns Bayer’s patent EP 2 305 255, which expired in December 2022. The patent protects the
For now, Formycon cannot launch its biosimilar of the macular degeneration treatment Eylea in various European markets. Munich Regional Court yesterday granted Regeneron and Bayer a preliminary
total 1 pages, 6 items
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
